Next, to investigate the tumor initiation competency and engraftment potential of these cells we next assessed the in vivo growth rates and latencies of tumors that developed following subcutaneous injection of EWS-iPS or CHLA-10 parental cell lines into immune-compromised mice. The gene discussed is EWSR1; the disease is neoplasm.